Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2005
10/18/2005US6955900 for complemetary determining regions (CDR) of immunoglobulin heavy/light chains displayed on the surface of filamentous phage particles
10/18/2005US6955899 comprises collagen-like domain; tissue remodeling
10/18/2005US6955897 Number of accessory gland proteins from Drosophila. The invention also provides an accessory gland protein which is toxic to insect cells and can be used to kill or inhibit the development of insects. Methods of controlling insects are
10/18/2005US6955885 Human stanniocalcin-alpha
10/18/2005US6955880 Primer composition and method of using the same in the detection of Shigella sonnei
10/18/2005US6955878 Apparatus for analyzing samples using linear probe array
10/18/2005US6955874 Kits employing oligonucleotide-binding e-tag probes
10/18/2005US6955872 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics
10/18/2005CA2045012C Detection of poor metabolizers of drugs
10/13/2005WO2005095647A1 METHOD OF SCREENING siRNA
10/13/2005WO2005095599A1 Novel fluorescent protein and gene encoding the same
10/13/2005WO2005094851A1 Water-soluble fraction extracted from animal organ, method of producing the same, reverse transcription inhibitor, reverse transcriptase inhibitor, viral growth inhibitor and medicinal compositions
10/13/2005WO2005094485A2 Drug screening
10/13/2005WO2005094453A2 Cospeptin, cosmedin and their uses
10/13/2005WO2005094356A2 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
10/13/2005WO2005076925A3 Dutp based compositions for reducing primer-aggregate formation during nucleic acid amplification
10/13/2005WO2005073380A3 Regulated polymerase iii expression systems and related methods
10/13/2005WO2005067648A3 Multiplex spatial profiling of gene expression
10/13/2005WO2005065328A3 Macrophage migration inhibitory factor (mif) as marker for urological inflammatory disease
10/13/2005WO2005060553A8 Geraniol synthase, methods of production and uses thereof
10/13/2005WO2005058479A3 Methods for synthesis of encoded libraries
10/13/2005WO2005038035A3 Methods for producing and using in vivo pseudotyped retroviruses
10/13/2005WO2005031002A3 Synthetic lethal screen using rna interference
10/13/2005WO2005019801A3 Method for rapid identification of molecules with functional activity towards biomolecular targets
10/13/2005WO2005014788A3 Tssk4: a human testis specific serine/threonine kinase
10/13/2005WO2005010205A3 Biomarkers fo aggrecanase activity
10/13/2005WO2005001055A3 Stabilized immunomodulatory oligonucleotides
10/13/2005WO2004113872A3 Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces
10/13/2005WO2004092328A3 Novel beta-tubulin protein of candida glabrata and methods for its use
10/13/2005WO2004092327A3 Method of generating size standard nucleic acids
10/13/2005WO2004081173A3 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
10/13/2005WO2004078994A3 Methods for detection of genetic disorders
10/13/2005WO2004072253A3 Human excitatory amino acid transporter-2 gene promoter and uses thereof
10/13/2005WO2004054436A3 Calcium-independent phospholipase a2 induces ischemic ventricular arrhythmias and decreases infarction size
10/13/2005WO2003088919A3 Compositions and methods for diagnostics and therapeutics for hydrocephalus
10/13/2005WO2003069980A3 Precise breeding
10/13/2005US20050229272 Compositions and methods for gene silencing
10/13/2005US20050229267 Precise breeding
10/13/2005US20050229263 Transgenesis by sperm-mediated gene transfer
10/13/2005US20050227939 Modulation of kallikrein 6 expression
10/13/2005US20050227938 Antisense modulation of TFAP2C expression
10/13/2005US20050227937 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
10/13/2005US20050227936 RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
10/13/2005US20050227935 Controlling gene expression; mixture of small nucleic acids
10/13/2005US20050227934 Diabetes; DNA or RNA molecules comprising at least ten contiguous bases having a sequence in a pancreatic islet microRNA
10/13/2005US20050227917 Gene products differentially expressed in cancerous cells and their methods of use II
10/13/2005US20050227911 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
10/13/2005US20050227329 Recombinant fibroblast growth factor analogs
10/13/2005US20050227327 Nicotinamide riboside kinase compositions and methods for using the same
10/13/2005US20050227326 Obtaining vector comprising a modified PLAC4 having a mutation in one or more Pribnow box-like sequences into which gene encoding target protein has been inserted; reduction in gene expression when vector is cloned in bacteria; transformation
10/13/2005US20050227325 Recombinant polynucleotide
10/13/2005US20050227324 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment
10/13/2005US20050227323 polynucleotide having nucleic acid sequences, encoding and expressing calcium-independent phospholipase A2 epsilon (iPLA2 epsilon ); for catalysis and hydrolysis of lipids in living cell biosystem; iPLA2 epsilon as a pharmacological target in drug screening anti-obesity drugs
10/13/2005US20050227321 Producing antimicrobial peptides (AMPs) by using microbes; not necessary to offset the positive charges of multiple copies of AMPs in multimeric constructs; enables the use of a wider range of multimers and carrier peptides
10/13/2005US20050227319 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants, fungi and microorganisms
10/13/2005US20050227318 Site-specific incorporation of redox active amino acids into proteins
10/13/2005US20050227317 Mammalian expression system
10/13/2005US20050227316 Using restriction enzyme digestion and ligase sealing to generate vector comprising preferential gene sequences; directed protein evolution
10/13/2005US20050227311 Novel carotenoid ketolases
10/13/2005US20050227303 Method and composition for diagnosis of melanocytic lesions
10/13/2005US20050227292 Allergenic protein complex of natural rubber latex
10/13/2005US20050227291 cyclic peptide consisting of three genetically encodable amino acid residues,at least one of said amino acid residues is a serine, threonine, or cysteine; employed in a variety of research and medical applications, including methods of treating a patient for hepatitis C infection.
10/13/2005US20050227285 Control of gene expression in eukaryotic cells
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227280 Proteases
10/13/2005US20050227273 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
10/13/2005US20050227272 Isolated nucleic acid with polynucleotide encoding a polypeptide that interacts with I kappa B alpha probe; diagnosis or pre-diagnosis of Type 1 diabetes in an individual
10/13/2005US20050227270 Alternatively spliced isoforms of sodium channel, voltage gated, type XI, alpha (SCN11A)
10/13/2005US20050227262 polynucleotides that code for polypeptide comprising beta-ketoacyl synthase, acetyl transferase, dehydratase, methyltransferase, ketoreductase, and acyl carrier proteins; anticholesterol agents produced by Monascus
10/13/2005US20050227259 Enzyme-free isothermal exponential amplification of nucleic acids and nucleic acid analog signals
10/13/2005US20050227257 Double stranded linear nucleic acid probe and uses thereof
10/13/2005US20050227254 useful as labels when attached to biomolecules such as natural or modified polynucleotides, oligonucleotides, nucleosides, nucleotides, carbohydrates and peptides, comprising a fluorescent dyes; genetic probes
10/13/2005US20050227250 Human Elk, a voltage-gated potassium channel subunit
10/13/2005US20050227247 Contacting a target nucleic acid sequence with PCR reagents of primers and a polymerase enzyme, and an oligonucleotide probe; hybridizing to a target polynucleotide sequence; a fluorescer molecule attached to a first end of the oligonucleotide and a quencher molecule
10/13/2005US20050227238 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
10/13/2005US20050227227 Nucleic acid oligomers; protease, reverse transcriptase; labeled oligonucleotide that specifically hybridizes; determine appropriate treatment
10/13/2005US20050226934 Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
10/13/2005US20050226895 vaccine to protect salmon against infection by Piscirickettsia salmonis, a gramnegative bacteria; salmonid rickettsial septicaemia
10/13/2005US20050226881 Isolated peptide which binds to HLA-Cw*07 and uses thereof
10/13/2005US20050226812 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
10/13/2005CA2561702A1 Methods for altering protein production rates
10/13/2005CA2560011A1 Cospeptin, cosmedin and their uses
10/13/2005CA2556227A1 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
10/12/2005EP1584684A1 Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
10/12/2005EP1584624A1 A full-length polynucleotide coding chicken type ii collagen and the use of it
10/12/2005EP1584058A2 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein
10/12/2005EP1583949A2 Compositions and methods for detecting west nile virus
10/12/2005EP1583948A2 High-sensitivity assays for pathogen detection using metal-enhanced fluorescence
10/12/2005EP1583843A2 Nucleic acid amplification
10/12/2005EP1583840A2 Target-dependent transcription
10/12/2005EP1583823A2 Isolation and identification of cross-reactive t cells
10/12/2005EP1583782A2 Cationic graft-copolymer for non-viral gene delivery vector
10/12/2005EP1583771A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
10/12/2005EP1583770A2 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
10/12/2005EP1583766A1 Process for preparing phosphorodiamidites
10/12/2005EP1583556A1 Sequences diagnostic for foot and mouth disease
10/12/2005EP1583517A2 Methods and products for treating staphylococcal infections
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1583501A2 Novel compositions and methods in cancer
10/12/2005EP0793723B1 New staphylokinase derivatives
1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 899